Increased levels of the major pro-angiogenic factor VEGF and its receptors can be produced by cancer cells and have been associated with resistance to chemotherapy in a variety of human tumor models, including colorectal, gastric, sarcoma, and pancreatic cancers (62–65). Here, VEGFA is linked to neoplasm.